![Charles Williams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 401 579 $ al 31/08/2026
Charles Williams is Secretary & Chief Operating Officer at Surrozen, Inc. since 2025.
Formerly, Mr. Williams was Head-Corporate Development at Jazz Pharmaceuticals Plc from 2013 to 2020 and Director-Corporate & Business Development at MAP Pharmaceuticals LLC from 2008 to 2013.
Mr. Williams completed undergraduate education at Cornell University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SURROZEN INC 0,16 % | 15/06/2026 | 18.237 ( 0,16 % ) | 401 579 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SURROZEN, INC. | Director de Operaciones | 01/02/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/11/2020 |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Corporate Officer/Principal | 01/01/2013 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Surrozen, Inc.
 Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
